Differential effects of oral doxercalciferol (Hectorol) or paricalcitol (Zemplar) in the Cyp27b1-null mouse model of uremia.

Author: AkhouayriOmar, ArabianAlice, KnutsonJoyce C, St-ArnaudRené, StrugnellStephen A

Paper Details 
Original Abstract of the Article :
Kidney disease patients experience declining calcitriol levels and develop secondary hyperparathyroidism (SHPT). Animal models of uremia based on 5/6 nephrectomy (NTX) do not consistently reproduce this calcitriol deficiency. We developed an animal model, the NTX Cyp27b1-null mouse, which completely...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1159/000329663

データ提供:米国国立医学図書館(NLM)

Calcitriol Deficiency in Uremia: A New Animal Model

Kidney disease, like a slow desert wind, can erode the body's vital functions. This study explores the challenges of modeling calcitriol deficiency, a common complication of kidney disease, in laboratory animals.

Developing a Novel Animal Model: Addressing the Gap

The researchers developed a new animal model, the NTX Cyp27b1-null mouse, which completely lacks endogenous calcitriol, the active form of vitamin D. This is like discovering a new desert environment with unique characteristics that allow us to study specific ecological phenomena.

Evaluating Vitamin D Analogs: A Crucial Step

The new animal model provides a valuable tool for evaluating the effectiveness of vitamin D analogs in treating calcitriol deficiency and secondary hyperparathyroidism, a common complication of kidney disease. This is like finding a new and effective source of water in the desert, offering a solution to the challenges of hydration and survival.

Dr. Camel's Conclusion

The development of the NTX Cyp27b1-null mouse model provides a significant advancement in understanding and treating calcitriol deficiency in kidney disease. This new model opens up exciting avenues for research and development of new therapies to address the specific challenges of this debilitating condition.
Date :
  1. Date Completed 2015-06-22
  2. Date Revised 2019-12-10
Further Info :

Pubmed ID

21849802

DOI: Digital Object Identifier

10.1159/000329663

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.